| Dr Barry Peterson Welch, MD | |
|
424 Yellowstone Ave, Suite 110, Cody, WY 82414-9318 | |
| (307) 587-5538 | |
| Not Available |
| Full Name | Dr Barry Peterson Welch |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 33 Years |
| Location | 424 Yellowstone Ave, Cody, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437157484 | NPI | - | NPPES |
| 110675900 | Medicaid | WY | |
| 180023255 | Other | WY | RAILROAD MEDICARE |
| 306944 | Other | WY | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 5652A (Wyoming) | Primary |
| Entity Name | Northern Wyoming Ophthalmology, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215928429 PECOS PAC ID: 1759364136 Enrollment ID: O20040608000538 |
News Archive
University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.
BioCen Natural Products Development Group President Daniel J. Kennedy today commented, "We are pleased to announce that the development of BNPD's first commercial health drink, Vitamin "X" is near completion." For the past 8 weeks, BNPD has been performing test market analysis to determine the best flavor(s) and percentage of Astaxanthin actives for each bottle.
comScore, Inc., a leader in measuring the digital world, and ImpactRx, a pharmaceutical insights company, today released the first in a series of reports from the comScore/ImpactRx Physician Behavioral Measurement™ solution, a unique digital measurement solution that measures physicians' actual online and mobile behaviors.
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, announced today it will extend the capabilities of its Sequence Enrichment Solution by offering Methyl-Seq and Ultra-Deep Resequencing applications.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barry Peterson Welch, MD 424 Yellowstone Ave, Suite 110, Cody, WY 82414-9318 Ph: (307) 587-5538 | Dr Barry Peterson Welch, MD 424 Yellowstone Ave, Suite 110, Cody, WY 82414-9318 Ph: (307) 587-5538 |
News Archive
University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.
BioCen Natural Products Development Group President Daniel J. Kennedy today commented, "We are pleased to announce that the development of BNPD's first commercial health drink, Vitamin "X" is near completion." For the past 8 weeks, BNPD has been performing test market analysis to determine the best flavor(s) and percentage of Astaxanthin actives for each bottle.
comScore, Inc., a leader in measuring the digital world, and ImpactRx, a pharmaceutical insights company, today released the first in a series of reports from the comScore/ImpactRx Physician Behavioral Measurement™ solution, a unique digital measurement solution that measures physicians' actual online and mobile behaviors.
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, announced today it will extend the capabilities of its Sequence Enrichment Solution by offering Methyl-Seq and Ultra-Deep Resequencing applications.
› Verified 8 days ago